Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXH2MG
|
||||
| Drug Name |
4-(5-fluoro-2-hydroxyphenyl)-2-hydroxy-4-methyl-N-(4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-2-(trifluoromethyl)pentanamide
|
||||
| Synonyms |
CHEMBL196374
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H20F4N2O5
|
||||
| Canonical SMILES |
CC1=NOC(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cc(F)ccc3O)C(F)(F)F)cc12
|
||||
| InChI |
InChI=1S/C22H20F4N2O5/c1-11-15-9-13(5-6-14(15)18(30)33-28-11)27-19(31)21(32,22(24,25)26)10-20(2,3)16-8-12(23)4-7-17(16)29/h4-9,29,32H,10H2,1-3H3,(H,27,31)
|
||||
| InChIKey |
NLPNUYHHRWOSGM-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Progesterone receptor | Target Info | [1587926] | ||
| mRNA of androgen receptor | Target Info | [1587926] | |||
| Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.